These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 19786544

  • 1. Cutting Edge: OX40 agonists can drive regulatory T cell expansion if the cytokine milieu is right.
    Ruby CE, Yates MA, Hirschhorn-Cymerman D, Chlebeck P, Wolchok JD, Houghton AN, Offner H, Weinberg AD.
    J Immunol; 2009 Oct 15; 183(8):4853-7. PubMed ID: 19786544
    [Abstract] [Full Text] [Related]

  • 2. Dominant role of antigen dose in CD4+Foxp3+ regulatory T cell induction and expansion.
    Turner MS, Kane LP, Morel PA.
    J Immunol; 2009 Oct 15; 183(8):4895-903. PubMed ID: 19801514
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. OX40-mediated differentiation to effector function requires IL-2 receptor signaling but not CD28, CD40, IL-12Rbeta2, or T-bet.
    Williams CA, Murray SE, Weinberg AD, Parker DC.
    J Immunol; 2007 Jun 15; 178(12):7694-702. PubMed ID: 17548606
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Protein kinase B/Akt signals impair Th17 differentiation and support natural regulatory T cell function and induced regulatory T cell formation.
    Pierau M, Engelmann S, Reinhold D, Lapp T, Schraven B, Bommhardt UH.
    J Immunol; 2009 Nov 15; 183(10):6124-34. PubMed ID: 19841181
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Ox40 costimulation enhances the development of T cell responses induced by dendritic cells in vivo.
    De Smedt T, Smith J, Baum P, Fanslow W, Butz E, Maliszewski C.
    J Immunol; 2002 Jan 15; 168(2):661-70. PubMed ID: 11777959
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. OX40 Agonist Tumor Immunotherapy Does Not Impact Regulatory T Cell Suppressive Function.
    Polesso F, Sarker M, Weinberg AD, Murray SE, Moran AE.
    J Immunol; 2019 Oct 01; 203(7):2011-2019. PubMed ID: 31434709
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. B lymphocytes treated in vitro with antigen coupled to cholera toxin B subunit induce antigen-specific Foxp3(+) regulatory T cells and protect against experimental autoimmune encephalomyelitis.
    Sun JB, Czerkinsky C, Holmgren J.
    J Immunol; 2012 Feb 15; 188(4):1686-97. PubMed ID: 22250081
    [Abstract] [Full Text] [Related]

  • 20. IQGAP1 restrains T-cell cosignaling mediated by OX40.
    Okuyama Y, Nagashima H, Ushio-Fukai M, Croft M, Ishii N, So T.
    FASEB J; 2020 Jan 15; 34(1):540-554. PubMed ID: 31914585
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.